CIK: 0001346824 · Show all filings
Period: Q3 2016 (← Previous) (Next →)
Filing Date: Nov 14, 2016
Total Value ($000): $969,369 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| WVE | WAVE LIFE SCIENCES PTE LTD | 7,088,651 | $230,168 | 23.7% | $15.68 | +50.7% | SHS | Y95308105 |
| — | ACHILLION PHARMACEUTICALS INC | 12,033,220 | $97,469 | 10.1% | $6.45 | — | COM | 00448Q201 |
| ASND | ASCENDIS PHARMA A S | 3,681,491 | $73,998 | 7.6% | $16.44 | — | SPONSORED ADR | 04351P101 |
| — | AVEXIS INC | 1,732,274 | $71,387 | 7.4% | $30.41 | — | COM | 05366U100 |
| — | AXOVANT SCIENCES LTD | 5,000,000 | $70,000 | 7.2% | $20.38 | — | COM | G0750W104 |
| — | NEKTAR THERAPEUTICS | 3,664,154 | $62,950 | 6.5% | $14.17 | — | COM | 640268108 |
| ARDX | ARDELYX INC | 3,266,045 | $42,263 | 4.4% | $10.51 | -0.4% | COM | 039697107 |
| ACRS | ACLARIS THERAPEUTICS INC | 1,547,152 | $39,623 | 4.1% | $19.34 | +9.7% | COM | 00461U105 |
| TGTX | TG THERAPEUTICS INC | 4,631,114 | $35,845 | 3.7% | $10.06 | -36.1% | COM | 88322Q108 |
| — | MERUS N V | 2,656,166 | $31,451 | 3.2% | $13.32 | — | COM | 98978L204 |
| — | AQUINOX PHARMACEUTICALS INC | 2,191,977 | $29,285 | 3.0% | $13.67 | — | COM | 03842B101 |
| — | AIMMUNE THERAPEUTICS INC | 1,292,940 | $19,394 | 2.0% | $20.75 | — | COM | 00900T107 |
| — | FOAMIX PHARMACEUTICALS LTD | 1,820,138 | $16,854 | 1.7% | $9.26 | — | SHS | M46135105 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 754,411 | $15,941 | 1.6% | $13.67 | 0.0% | COM | 74366E102 |
| — | PROTEON THERAPEUTICS INC | 1,626,931 | $15,179 | 1.6% | $11.31 | — | COM | 74371L109 |
| — | DICERNA PHARMACEUTICALS INC | 2,428,571 | $14,280 | 1.5% | $28.25 | — | COM | 253031108 |
| BCRX | BIOCRYST PHARMACEUTICALS | 2,989,795 | $13,185 | 1.4% | $9.58 | -58.3% | COM | 09058V103 |
| — | STRONGBRIDGE BIOPHARMA PLC | 2,501,667 | $13,059 | 1.3% | $7.60 | — | SHS USD | G85347105 |
| — | AUDENTES THERAPEUTICS INC | 707,426 | $12,599 | 1.3% | $17.81 | — | COM | 05070R104 |
| — | DIMENSION THERAPEUTICS INC | 1,548,033 | $12,369 | 1.3% | $10.25 | — | COM | 25433V105 |
| — | ACCELERON PHARMA INC | 318,565 | $11,529 | 1.2% | $36.19 | — | COM | 00434H108 |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 1,525,424 | $11,212 | 1.2% | $6.48 | 0.0% | COM | 04280A100 |
| — | TENAX THERAPEUTICS INC | 2,389,700 | $5,532 | 0.6% | $3.92 | — | COM | 88032L100 |
| ONC | BEIGENE LTD | 170,000 | $5,238 | 0.5% | $29.31 | — | SPONSORED ADR | 07725L102 |
| — | ALCOBRA LTD | 2,044,756 | $5,051 | 0.5% | $6.39 | — | SHS | M2239P109 |
| — | EIGER BIOPHARMACEUTICALS INC | 354,200 | $4,743 | 0.5% | $16.17 | — | COM | 28249U105 |
| SGMO | SANGAMO BIOSCIENCES INC | 899,438 | $4,164 | 0.4% | $8.61 | -40.9% | COM | 800677106 |
| — | AEGLEA BIOTHERAPEUTICS INC | 336,134 | $2,155 | 0.2% | $4.86 | — | COM | 00773J103 |
| — | ARCA BIOPHARMA INC | 521,606 | $1,476 | 0.2% | $4.96 | — | COM PAR$.001 | 00211Y407 |
| — | AKARI THERAPEUTICS PLC | 114,039 | $970 | 0.1% | $24.00 | — | SPONSORED ADR | 00972G108 |